LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Nexalin Technology (NASDAQ: NXL)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ NXL Nexalin Technology
Owens David / director, officer: Chief Medical Officer
10/28/2024
Buy
$2.19
500
$1K
148,293

COPYRIGHT ©2023 HEALTH STOCKS HUB